Adverse events · Percutaneous nephrolithotomy
Systemic TXA showed no clear difference in adverse events compared with no TXA (placebo or usual care) (low certainty).
1 finding from 1 review
Adverse events · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Combination therapy showed no clear difference in adverse events compared with anticholinergics (moderate certainty).
1 finding from 1 review
Adverse events · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Combination therapy probably leads to higher adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Adverse events · men with lower urinary tract symptoms secondary to benign prostatic obstruction
Combination therapy showed no clear difference in adverse events compared with alpha‐blockers (low certainty).
1 finding from 1 review
Adverse events · men with ED
Ginseng showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Adverse events · adult men with premature ejaculation
SSRI probably leads to higher adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Adverse events · participants with a prior history of nephrolithiasis
1 finding from 1 review
Adverse events · participants with chronic prostatitis/chronic pelvic pain syndrome
5‐alpha reductase inhibitors showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Adverse events · participants with chronic prostatitis/chronic pelvic pain syndrome
Antibiotic therapy showed no clear difference in adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Adverse events · participants with chronic prostatitis/chronic pelvic pain syndrome
Anti‐inflammatories showed no clear difference in adverse events compared with control (low certainty).
1 finding from 1 review
Adverse events · participants with chronic prostatitis/chronic pelvic pain syndrome
Phytotherapy showed no clear difference in adverse events compared with placebo or other agents (low certainty).
1 finding from 1 review
Adverse events · participants with chronic prostatitis/chronic pelvic pain syndrome
Botulinum toxin A showed no clear difference in adverse events compared with placebo (low certainty).
1 finding from 1 review
Adverse events · participants with chronic prostatitis/chronic pelvic pain syndrome
1 finding from 1 review
Adverse events · participants with chronic prostatitis/chronic pelvic pain syndrome
Traditional Chinese Medicine showed no clear difference in adverse events compared with placebo or usual care (low certainty).
1 finding from 1 review
Adverse events
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events
The review found no eligible studies for this question.
2 findings from 1 review
Adverse events
PDEI may leads to higher adverse events compared with placebo (low certainty).
1 finding from 1 review
Adverse events
PDEI showed no clear difference in adverse events compared with alpha‐blockers (low certainty).
1 finding from 1 review
Adverse events · participants with chronic prostatitis/chronic pelvic pain syndrome
1 finding from 1 review
Adverse events · participants with chronic prostatitis/chronic pelvic pain syndrome
Acupuncture showed no clear difference in adverse events compared with sham procedure (low certainty).
1 finding from 1 review